These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 15054710

  • 1. [The diagnostic evaluation and therapeutic basis of immediate release methylphenidate in attention deficit hyperactivity disorder].
    Valdizán JR.
    Rev Neurol; ; 38(6):501-6. PubMed ID: 15054710
    [Abstract] [Full Text] [Related]

  • 2. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS, Guilleminault C, Li HY, Yang CM, Wu YY, Chen NH.
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [Abstract] [Full Text] [Related]

  • 3. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [Abstract] [Full Text] [Related]

  • 4. [Nocturnal polysomnographic study in children with attention deficit hyperactivity disorder].
    Bernal Lafuente M, Valdizan JR, Garcia Campayo J.
    Rev Neurol; 2004 Feb; 38 Suppl 1():S103-10. PubMed ID: 15011163
    [Abstract] [Full Text] [Related]

  • 5. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
    Marcus SC, Wan GJ, Kemner JE, Olfson M.
    Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
    [Abstract] [Full Text] [Related]

  • 6. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.
    Williams LM, Hermens DF, Palmer D, Kohn M, Clarke S, Keage H, Clark CR, Gordon E.
    Biol Psychiatry; 2008 May 15; 63(10):917-26. PubMed ID: 18272140
    [Abstract] [Full Text] [Related]

  • 7. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL.
    Clin Ther; 2008 May 15; 30(5):942-57. PubMed ID: 18555941
    [Abstract] [Full Text] [Related]

  • 8. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun 15; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 9. The relationship between regional cerebral blood flow and response to methylphenidate in children with attention-deficit hyperactivity disorder: comparison between non-responders to methylphenidate and responders.
    Cho SC, Hwang JW, Kim BN, Lee HY, Kim HW, Lee JS, Shin MS, Lee DS.
    J Psychiatr Res; 2007 Sep 15; 41(6):459-65. PubMed ID: 16839567
    [Abstract] [Full Text] [Related]

  • 10. The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: a matched case-control study.
    Galland BC, Tripp EG, Taylor BJ.
    J Sleep Res; 2010 Jun 15; 19(2):366-73. PubMed ID: 20050995
    [Abstract] [Full Text] [Related]

  • 11. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL, Wigal SB, Bukstein OG, Boellner SW, Abikoff HB, Turnbow JM, Civil R.
    Clin Ther; 2009 Aug 15; 31(8):1844-55. PubMed ID: 19808143
    [Abstract] [Full Text] [Related]

  • 12. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
    Walitza S, Kämpf K, Artamonov N, Romanos M, Gnana Oli R, Wirth S, Warnke A, Gerlach M, Stopper H.
    Toxicol Lett; 2009 Jan 10; 184(1):38-43. PubMed ID: 19015014
    [Abstract] [Full Text] [Related]

  • 13. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.
    Levin FR, Evans SM, Brooks DJ, Garawi F.
    Drug Alcohol Depend; 2007 Feb 23; 87(1):20-9. PubMed ID: 16930863
    [Abstract] [Full Text] [Related]

  • 14. Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Quinn D, Bode T, Reiz JL, Donnelly GA, Darke AC.
    J Clin Pharmacol; 2007 Jun 23; 47(6):760-6. PubMed ID: 17395894
    [Abstract] [Full Text] [Related]

  • 15. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
    Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T.
    Biol Psychiatry; 2006 May 01; 59(9):829-35. PubMed ID: 16373066
    [Abstract] [Full Text] [Related]

  • 16. [Attention deficit hyperactivity disorder in adults: a clinical and therapeutic characterization].
    Ramos-Quiroga JA, Bosch-Munsó R, Castells-Cervelló X, Nogueira-Morais M, García-Gimenez E, Casas-Brugué M.
    Rev Neurol; 2006 May 01; 42(10):600-6. PubMed ID: 16703528
    [Abstract] [Full Text] [Related]

  • 17. Effect of methylphenidate on auditory event related potential in boys with attention deficit hyperactivity disorder.
    Ozdag MF, Yorbik O, Ulas UH, Hamamcioglu K, Vural O.
    Int J Pediatr Otorhinolaryngol; 2004 Oct 01; 68(10):1267-72. PubMed ID: 15364497
    [Abstract] [Full Text] [Related]

  • 18. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.
    Child Care Health Dev; 2006 Sep 01; 32(5):575-83. PubMed ID: 16919137
    [Abstract] [Full Text] [Related]

  • 19. [Attention deficit disorder: multidisciplinary observational study over 1 year].
    Chambry J, Billard C, Guinard M, Lacaze E, Idiart ME, Delteil-Pinton F, Cohen de Lara A.
    Encephale; 2011 Jun 01; 37(3):180-90. PubMed ID: 21703433
    [Abstract] [Full Text] [Related]

  • 20. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder.
    Huang YS, Chao CC, Wu YY, Chen YY, Chen CK.
    Psychiatry Clin Neurosci; 2007 Jun 01; 61(3):219-25. PubMed ID: 17472588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.